Pfizer has accused the European Union of hampering its production of Covid vaccines.
The US drugmaker, which supplies Britain and more than 70 other countries with injections of the coronavirus, said new EU rules on the free flow of goods across borders are damaging its ability to export the vaccine.
The rules require manufacturers to seek approval from Brussels before exporting each package of jabs, which has caused “a significant administrative burden and some uncertainty,” said Danny Hendrikse, vice president of global sourcing at the pharmaceutical giant.
“At the end of the day, what we would like our colleagues to do is focus on the manufacture and distribution of the vaccine,” he said.
The EU’s medical regulator told Germany and France on Wednesday that they had no reason to stop using AstraZeneca vaccines after its rollout stopped due to concerns about an illness rare blood.
EU leaders had threatened to block exports of the vaccine to Britain while demanding that AstraZeneca increase production on the continent.